Alberto Tejedor

3.3k total citations
79 papers, 2.3k citations indexed

About

Alberto Tejedor is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alberto Tejedor has authored 79 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Nephrology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alberto Tejedor's work include Ion Transport and Channel Regulation (13 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Dialysis and Renal Disease Management (6 papers). Alberto Tejedor is often cited by papers focused on Ion Transport and Channel Regulation (13 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Dialysis and Renal Disease Management (6 papers). Alberto Tejedor collaborates with scholars based in Spain, Canada and United States. Alberto Tejedor's co-authors include Alberto Lázaro, Sonia Camaño, Blanca Humanes, M. Milagros Gómez-Gómez, Estefanía Moreno-Gordaliza, Luís Puente‐Maestu, Orson W. Moe, Robert J. Alpern, Diego Esteban‐Fernández and Àlvar Agustí and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Alberto Tejedor

77 papers receiving 2.2k citations

Peers

Alberto Tejedor
Subhashini Bolisetty United States
Anne Dawnay United Kingdom
Mehmet Koç Türkiye
William Strauss United States
Anthony G.W. Norden United Kingdom
Subhashini Bolisetty United States
Alberto Tejedor
Citations per year, relative to Alberto Tejedor Alberto Tejedor (= 1×) peers Subhashini Bolisetty

Countries citing papers authored by Alberto Tejedor

Since Specialization
Citations

This map shows the geographic impact of Alberto Tejedor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Tejedor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Tejedor more than expected).

Fields of papers citing papers by Alberto Tejedor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Tejedor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Tejedor. The network helps show where Alberto Tejedor may publish in the future.

Co-authorship network of co-authors of Alberto Tejedor

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Tejedor. A scholar is included among the top collaborators of Alberto Tejedor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Tejedor. Alberto Tejedor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández‐Romero, Ismael, Carolina Puertas, Beatriz Sánchez‐Álamo, et al.. (2020). Alteraciones graves del potasio plasmático: prevalencia, caracterización clínica-electrocardiográfica y su pronóstico. REC CardioClinics. 56(2). 98–107. 3 indexed citations
2.
Humanes, Blanca, Sonia Camaño, Beatriz López‐Manzanares, et al.. (2020). Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency. Antioxidants. 9(9). 821–821. 27 indexed citations
3.
Castillo-Rodríguez, Esmeralda, Raúl Fernández-Prado, Raquel Esteras, et al.. (2018). Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins. 10(7). 300–300. 109 indexed citations
4.
Moreno-Gordaliza, Estefanía, Diego Esteban‐Fernández, Alberto Lázaro, et al.. (2018). Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity. Journal of Lipid Research. 59(9). 1561–1574. 24 indexed citations
5.
Arroyo, Roberto Alcázar & Alberto Tejedor. (2017). Guías ¿que no guían? Sobre hiponatremia. Nefrología. 37(4). 357–359. 1 indexed citations
6.
Lázaro, Alberto, Blanca Humanes, Marina Mojena, et al.. (2016). Beneficial Effect of Short Pretransplant Period of Hypothermic Pulsatile Perfusion of the Warm-Ischemic Kidney after Cold Storage: Experimental Study. BioMed Research International. 2016. 1–8. 2 indexed citations
7.
Moreno-Gordaliza, Estefanía, Diego Esteban‐Fernández, Alberto Lázaro, et al.. (2016). MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy. Talanta. 164. 16–26. 40 indexed citations
8.
Santiago, María José, Sarah N. Fernández, Alberto Lázaro, et al.. (2016). Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets. PLoS ONE. 11(2). e0149013–e0149013. 7 indexed citations
9.
Fermoselle, Clara, Elena García‐Arumí, Ester Puig‐Vilanova, et al.. (2013). Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice. Experimental Physiology. 98(9). 1349–1365. 51 indexed citations
10.
Singh, Parmanand, Ahmed Tawakol, Marina Mojena, et al.. (2013). GM-CSF ENHANCES GLYCOLYTIC ACTIVITY IN MACROPHAGES IN VITRO AND IMPROVES DETECTION OF ATHEROSCLEROTIC INFLAMMATION IN VIVO. Journal of the American College of Cardiology. 61(10). E1153–E1153. 1 indexed citations
11.
Fernández‐Sánchez, Ruth, Sergio Berzal, María Dolores Sánchez-Niño, et al.. (2012). AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation. Current Medicinal Chemistry. 19(23). 4014–4023. 12 indexed citations
12.
Camaño, Sonia, Alberto Lázaro, Estefanía Moreno-Gordaliza, et al.. (2010). Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage. Journal of Pharmacology and Experimental Therapeutics. 334(2). 419–429. 66 indexed citations
13.
Tejedor, Alberto & X Cuevas. (2008). Cuidado paliativo en el paciente con enfermedad renal crónica avanzado (grado 5) no susceptible de tratamiento dialítico. Nefrología. 28(3). 129–136. 10 indexed citations
14.
Neria, Fernando, María Ángeles Castilla, Juan J. P. Deudero, et al.. (2008). Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney International. 75(2). 227–234. 48 indexed citations
15.
Tejedor, Alberto. (2006). Atención domiciliaria al paciente urémico terminal no susceptible de diálisis. Nefrología. 26(3). 66–81. 5 indexed citations
16.
Riol‐Blanco, Lorena, Noelia Sánchez‐Sánchez, A.L. Torres, et al.. (2005). The Chemokine Receptor CCR7 Activates in Dendritic Cells Two Signaling Modules That Independently Regulate Chemotaxis and Migratory Speed. The Journal of Immunology. 174(7). 4070–4080. 187 indexed citations
17.
Riol‐Blanco, Lorena, Teresa Iglesias, Noelia Sánchez‐Sánchez, et al.. (2003). The neuronal protein Kidins220 localizes in a raft compartment at the leading edge of motile immature dendritic cells. European Journal of Immunology. 34(1). 108–118. 19 indexed citations
18.
Malpica, Norberto, et al.. (2003). Automatic quantification of viability in epithelial cell cultures by texture analysis. Journal of Microscopy. 209(1). 34–40. 16 indexed citations
19.
Tejedor, Alberto, et al.. (1993). Furosemide unveils hidden tubule dysfunction induced by a short term treatment with cyclosporin A in isogenic minipigs. Journal of the American Society of Nephrology. 4(3). 919. 2 indexed citations
20.
Alpern, Robert J., Shigeo Horie, Orson W. Moe, et al.. (1991). Chronic adaptations in proximal tubular H/HCO3 transporters.. PubMed. 33. S29–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026